Umoja's in vivo cell therapy fast-tracked by FDA A pioneer of in vivo cell therapy, Umoja has cleared another regulatory milestone by getting fast-track status for its lead blood cancer programme.

One of the pioneers of in vivo #celltherapy, #UmojaBiopharma, has cleared another regulatory milestone after getting a #fasttrackdesignation from the FDA for its lead candidate for #bloodcancers, partnered with #AbbVie.

FirstWord

#AbbVie #Biogen #BMS #CapstanTherapeutics #CARTtherapies #Gilead #JnJ #Novartis #ParvusTherapeutics #SAGETherapeutics #SupernusPharmaceuticals #UmojaBiopharma #4DMolecularTherapeutics #4DMT #Regeneron #Tecvayli #GSK #Dizal #UnicyciveTherapeutics #AstraZeneca
firstwordpharma.com/story/5978127